Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-05-10

FDA Approved: PROPYLTHIOURACIL — Original Application (Macleods Pharmaceuticals Limited)

View source ↗

Summary

FDA approved Macleods Pharmaceuticals Limited's original ANDA for Propylthiouracil, an antithyroid medication used to treat hyperthyroidism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Propylthiouracil (propylthiouracil)

Snippet

ORIG AP for PROPYLTHIOURACIL (PROPYLTHIOURACIL)